IP Library Granted Patent US 8,466,296
Granted Patent B2
US 8,466,296 · App. 12/532,937 · Granted Jun 18, 2013

Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]indol-8-ones

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,466,296
App. No.
12/532,937
Granted
Jun 18, 2013
Kind
B2
Abstract

Processes and intermediates are provided for the preparation of substituted aminomethyl 2,3,8,9-tetrahydiO-7H-1,4-dioxino[2.3-e]indo]-8-ones of the Formula (A) wherein the variables n, R and R 3 are as described herein. Such compounds are useful, for example, as dopamine receptor agonists.

Claims (94)

1. A compound of Formula 4 or a salt or hydrate thereof:

wherein:

n is the integer 0 or 1;

PG is an optionally substituted benzyl; and

R 3 is a ring substituent chosen from hydroxy, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkanoyloxy, amino, mono- or di-(C 1 -C 6 alkyl)amino, mono- or di-(C 1 -C 6 alkyl)aminocarbonyl and C 1 -C 6 alkylaminosulfonyl.

2. A compound or salt or hydrate thereof according to claim 1 , wherein the compound is (R)-2-((2-(benzyloxy)-4-nitrophenoxy)methyl)oxirane.

3. A process for preparing a compound of Formula 5 or a salt or hydrate thereof:

wherein:

n is the integer 0 or 1; and

R 3 is a ring substituent chosen from hydroxy, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkanoyloxy, amino, mono- or di-(C 1 -C 6 alkyl)amino, mono- or di-(C 1 -C 6 alkyl)aminocarbonyl and C 1 -C 6 alkylaminosulfonyl;

comprising cyclizing a compound of Formula 4 or a salt or hydrate thereof:

wherein PG is an optionally substituted benzyl;

for a time and under conditions effective to provide the compound of Formula 5 or a salt or hydrate thereof.

4. A process according to claim 3 , further comprising the step of alkylating a compound of Formula 3 or a salt or hydrate thereof:

with an alkylating agent of Formula:

wherein L is a leaving group;

for a time and under conditions effective to provide the compound of Formula 4 or salt or hydrate thereof.

5. A process according to claim 4 , wherein the compound of Formula 4 is (R)-2-((2-(benzyloxy)-4-nitrophenoxy)methyl)oxirane, and the compound of Formula 5 is (S)-(7-nitro-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanol.

6. A compound of Formula 7 or Formula 8 or a salt or hydrate of Formula 7 or Formula 8:

wherein:

n is the integer 0 or 1;

D is COOH or —COOR w ;

R w is C 1 -C 8 alkyl; and

R 3 is a ring substituent chosen from hydroxy, halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkanoyloxy, amino, mono- or di-(C 1 -C 6 alkyl)amino, mono- or di-(C 1 -C 6 alkyl)aminocarbonyl and C 1 -C 6 alkylaminosulfonyl.

7. A process for preparing a compound of Formula 7 or a salt or hydrate thereof:

wherein:

n is the integer 0 or 1;

D is COOH or —COOR w ;

R w is C 1 -C 8 alkyl; and

R 3 is a ring substituent chosen from hydroxy, halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkanoyloxy, amino, mono- or di-(C 1 -C 6 alkyl)amino, mono- or di-(C 1 -C 6 alkyl)aminocarbonyl and C 1 -C 6 alkylaminosulfonyl;

comprising contacting a compound of Formula 6 or a salt or hydrate thereof:

wherein:

W is CN or —COOR w ;

with water or a C 1 -C 8 alkanol for a time and under conditions effective to provide the compound of Formula 7 or a salt or hydrate thereof.

8. A process for preparing a compound of Formula 8 or a salt or hydrate thereof:

wherein:

n is the integer 0 or 1; and

R 3 is a ring substituent chosen from hydroxy, halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkanoyloxy, amino, mono- or di-(C 1 -C 6 alkyl)amino, mono- or di-(C 1 -C 6 alkyl)amino carbonyl and C 1 -C 6 alkylaminosulfonyl;

comprising reducing and cyclizing a compound of Formula 7 or a salt or hydrate thereof:

wherein:

D is COOH or —COOR w ; and

R w is C 1 -C 8 alkyl;

for a time and under conditions effective to provide the compound of Formula 8 or a salt or hydrate thereof.

9. A process for preparing a compound of Formula 9 or a salt or hydrate thereof:

wherein:

n is the integer 0 or 1; and

R 3 is a ring substituent chosen from hydroxy, halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkanoyloxy, amino, mono- or di-(C 1 -C 6 alkyl)amino, mono- or di-(C 1 -C 6 alkyl)aminocarbonyl and C 1 -C 6 alkylaminosulfonyl;

comprising:

contacting a compound of Formula 8 or a salt or hydrate thereof:

with toluenesulfonyl chloride for a time and under conditions effective to provide the compound of Formula 9 or a salt or hydrate thereof.

10. A process for preparing a compound of Formula A or a pharmaceutically acceptable salt or hydrate thereof:

wherein:

n is the integer 0 or 1;

R is optionally substituted phenylC 1 -C 2 alkyl; and

R 3 is a ring substituent chosen from hydroxy, halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkanoyloxy, amino, mono- or di-(C 1 -C 6 alkyl)amino, mono- or di-(C 1 -C 6 alkyl)aminocarbonyl and C 1 -C 6 alkylaminosulfonyl;

comprising:

contacting a compound of Formula 8 or a salt or hydrate thereof:

with toluenesulfonyl chloride for a time and under conditions effective to provide a compound of Formula 9 or a salt or hydrate thereof:

and

contacting the compound of Formula 9 or salt or hydrate thereof with RNH 2 for a time and under conditions effective to provide the compound of Formula A or a pharmaceutically acceptable salt or hydrate thereof.

11. A process according to claim 10 , wherein the compound of Formula A is:

12. A compound of Formula 12 or a salt or hydrate thereof:

wherein:

n is the integer 0 or 1;

R is optionally substituted benzyl; and

R 3 is a ring substituent chosen from hydroxy, halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkanoyloxy, amino, mono- or di-(C 1 -C 6 alkyl)amino, mono- or di-(C 1 -C 6 alkyl)aminocarbonyl and C 1 -C 6 alkylaminosulfonyl.

13. A process comprising:

contacting a compound of Formula 12 or a salt or hydrate thereof:

n is the integer 0 or 1:

R 3 is a ring substituent chosen from hydroxy, halogen, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkanoyloxy, amino, mono- or di-(C 1 -C 6 alkyl)amino, mono- or di-(C 1 -C 6 alkyl)aminocarbonyl and C 1 -C 6 alkylaminosulfonyl; and

R is optionally substituted benzyl;

with

wherein R w is C 1 -C 8 alkyl and X is a leaving group;

for a time and under conditions effective to provide the compound of Formula 13 or a salt or hydrate thereof and thereby forming a compound of Formula 13

wherein W is CN or COOR w .

14. A process according to claim 13 , further comprising the step of contacting a compound of Formula 11 or a salt or hydrate thereof:

with RNH 2 for a time and under conditions effective to provide the compound of Formula 12 or a salt or hydrate thereof.

15. A process of claim 13 additionally comprising contacting the compound of Formula 13 or a salt or hydrate thereof:

wherein:

W is CN or —COOR w ; and

R w is C 1 -C 8 alkyl;

with water or a C 1 -C 8 alkanol for a time and under conditions effective to provide the compound of Formula 14 or a salt or hydrate thereof

wherein R x is hydrogen or C 1 -C 8 alkyl.

16. A process according to claim 15 , further comprising the step of contacting a compound of Formula 12 or a salt or hydrate thereof:

wherein X is a leaving group;

for a time and under conditions effective to provide the compound of Formula 13 or a salt or hydrate thereof.

17. A process according to claim 10 , further comprising the step of reducing and cyclizing a compound of Formula 7 or a salt or hydrate thereof:

wherein:

D is COOH or —COOR w ; and

R w is C 1 -C 8 alkyl;

for a time and under conditions effective to provide the compound of Formula 8 or a salt or hydrate thereof.

18. A process according to claim 17 , further comprising the step of contacting a compound of Formula 6 or a salt or hydrate thereof:

wherein W is CN or —COOR w ;

with water or a C 1 -C 8 alkanol for a time and under conditions effective to provide the compound of Formula 7 or a salt or hydrate thereof.

Assignments (2)
SECURITY INTEREST Recorded Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2010
From: WANG, ZHE-QING; STAAB, ANDREW J.; SEEKAMP, CHRISTOPHER K.; LUKE, GEORGE P.
To: LIGAND PHARMACEUTICALS
Reel/Frame 024121/0417 →